» Articles » PMID: 2178329

The Glucose Transporter and Blood-brain Barrier of Human Brain Tumors

Overview
Journal Ann Neurol
Specialty Neurology
Date 1990 Dec 1
PMID 2178329
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The glucose transporter of the human brain has been localized to endothelial cells expressing the blood-brain barrier, but little is known regarding its mechanism of induction or whether its expression is exclusively linked with restricted vascular permeability. We investigated glucose transporter expression by vessels in human astrocytic tumors and pulmonary metastases to the brain using immunohistochemical techniques. Vessels in 9 of 10 low-grade astrocytomas and 8 of 10 anaplastic astrocytomas were positive for glucose transporter. Glioblastoma vessels were transporter-positive in only 2 of 10 specimens. Vessels in all three metastatic tumors were negative for the glucose transporter. The decrease in transporter expression observed in higher-grade tumors occurred independently of increases in vascular permeability. In low-grade astrocytomas and glioblastomas transporter expression and contrast enhancement were inversely related, but vessels in 6 of 9 anaplastic astrocytomas were transporter-positive despite contrast enhancement. These findings suggest that separate mechanisms induce the glucose transporter and the permeability restrictions of the human blood-brain barrier. They also have potential implications for the therapy and prognosis of astroglial neoplasms.

Citing Articles

Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering.

Liang Y, Iqbal Z, Lu J, Wang J, Zhang H, Chen X Mol Ther. 2022; 31(5):1207-1224.

PMID: 36245129 PMC: 10188644. DOI: 10.1016/j.ymthe.2022.10.008.


Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics.

Chan M, Huang W, Satpathy A, Su T, Hsiao M, Liu R Pharmaceutics. 2022; 14(2).

PMID: 35214188 PMC: 8875488. DOI: 10.3390/pharmaceutics14020456.


Quantitative protein expression of blood-brain barrier transporters in the vasculature of brain metastases of patients with lung and breast cancer.

Bao X, Wu J, Jiang J, Tien A, Sanai N, Li J Clin Transl Sci. 2021; 14(4):1265-1271.

PMID: 33566445 PMC: 8301582. DOI: 10.1111/cts.12978.


Effect of blood glucose level on standardized uptake value (SUV) in F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Eskian M, Alavi A, Khorasanizadeh M, Viglianti B, Jacobsson H, Barwick T Eur J Nucl Med Mol Imaging. 2018; 46(1):224-237.

PMID: 30350009 DOI: 10.1007/s00259-018-4194-x.


Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients.

Xu X, Yadav N, Knutsson L, Hua J, Kalyani R, Hall E Tomography. 2016; 1(2):105-114.

PMID: 26779568 PMC: 4710854. DOI: 10.18383/j.tom.2015.00175.